
Despite recent changes in corporate tax law, Ireland remains a valuable and attractive partner in the development and manufacture of biopharmaceuticals.
Rory Mullen is the West Coast director and senior vice president of IDA Ireland. For more information, email rory.mullen@ida.ie.

Despite recent changes in corporate tax law, Ireland remains a valuable and attractive partner in the development and manufacture of biopharmaceuticals.

Published: November 25th 2014 | Updated: